M. Herberhold et al. / Journal of Organometallic Chemistry 585 (1999) 234–240
239
tane and dried under high vacuum to give a red mi-
3.7. Cp*Rh(PMe3)(TePh)2 (4c)
crocrystalline powder (326 mg (79%), m.p. (dec.)
131°C). EI MS: m/e (relative intensity %): 803 (1,
[Cp*Rh]2(SPh)3+), 694 (2, [Cp*Rh(SPh)]2+), 532 (1,
Cp*Rh(PMe3)(SPh)2+), 456 (2, Cp*Rh(SPh)2+), 423
(6, Cp*Rh(PMe3)(SPh)+), 347 (28, Cp*Rh(SPh)+),
314 (1, Cp*Rh(PMe3)+), 238 (9, Cp*Rh+), 76 (74,
PMe3+), 61 (100, PMe2+). 1H-NMR (CDCl3, 270
MHz): 7.37 (d, J(HH)=7.9 Hz, 4H, H(2)/H(6)), 6.96
(dd, J(HH)=7.9 and 7.3 Hz, 4H, H(3)/H(5)), 6.87 (t,
J(HH)=7.3 Hz, 2H, H(4)), 1.66 (d, J(PH)=3.1 Hz,
15H, C5Me5), 1.45 (d, J(PH)=10.4 Hz, 9H, PMe3).
13C-NMR (CDCl3, 126 MHz): 144.2 (dd, J(RhC)=
0.8 Hz, J(PC)=4.4 Hz, C(1)), 133.1 (d, J(PC)=0.8
Hz, C(2)/C(6)), 127.1 (C(3)/C(5)), 122.47 (C(4)), 100.0
(dd, J(RhC)=4.9 Hz, J(PC)=3.3 Hz, C5Me5), 15.3
(dd, J(RhC)=0.5 Hz, J(PC)=33.5 Hz, PMe3), 9.5
(d, J(PC)=1.4 Hz, C5Me5).
A solution of Te2Ph2 (279 mg, 0.68 mmol) in 10 ml
of THF was slowly treated with 1.4 ml of a 1 M
solution of Li[BHEt3] in THF, and the mixture was
stirred for 15 min at r.t. The dark red solution thus
formed was added to a suspension of 3 (219 mg, 0.57
mmol) in 10 ml of THF. After 3 h stirring at r.t. the
solvent was removed from the resulting dark green
solution under vacuum and the residue chro-
matographed on Al2O3V. With pentane an orange–
yellow band of Te2Ph2 was eluated. Subsequent
eluation with toluene gave a green zone that was
taken to dryness under vacuum. The oily residue was
stirred in 10 ml of pentane for 30 min at r.t. and
then cooled to −78°C. After several hours the super-
natant liquid was decanted and the green microcrys-
talline solid dried under high vacuum (250 mg (61%),
m.p. (dec.) 103°C).). EI MS: m/e (relative intensity
%): 724 (7, Cp*Rh(PMe3)(TePh)2+), 519 (21,
Cp*Rh(PMe3)(TePh)+), 443 (47, Cp*Rh(TePh)+),
366 (15, Cp*RhTe+), 314 (12, Cp*Rh(PMe3)+), 238
(20, Cp*Rh+), 154 (100, Ph2+). 1H-NMR (CDCl3,
500 MHz): 7.76 (d, J(HH)=7.9 Hz, 4H, H(2)/H(6)),
7.15 (t, J(HH)=6.9 Hz, 2H, H(4)), 6.97 (dd, J(H)=
7.9 and 6.9 Hz, 4H, H(3)/H(5)), 1.89 (d, J(PH)=2.9
Hz, 15H, C5Me5), 1.70 (d, J(PH)=9.8 Hz, PMe3).
13C-NMR (CDCl3, 75.0 MHz): 141.2 (C(2)/C(6)),
127.5 (C(3)/C(5)), 125.8 (C(4)), 107.9 (dd, J(TeC)=
353 Hz, J(RhC)=0.5 Hz, J(PC)=3.5 Hz, C(1)), 99.6
(dd, J(RhC)=4.4 Hz, J(PC)=3.3 Hz, C5Me5), 20.9
(dd, J(TeC)=8 Hz, J(RhC)=0.5 Hz, J(PC)=35.4
Hz, PMe3), 10.8 (d, J(PC)=0.9 Hz, C5Me5).
3.6. Cp*Rh(PMe3)(SePh)2 (4b)
A solution of Se2Ph2 (233 mg, 0.75 mmol) in 10 ml
of THF was slowly treated with 1.5 ml of a 1 M
solution of Li[BHEt3] in THF and the mixture was
stirred for 15 min at r.t. A pale yellow solution was
formed which was added to a suspension of 3 (220
mg, 0.57 mmol) in 10 ml of THF. After 3 h stirring
at r.t. the solvent from the resulting dark red solution
was removed under vacuum, and then the residue
filtered through cellulose using 20 ml of
CH2Cl2:pentane (1:10). The filtrate was concentrated
to about 5 ml in volume, 30 ml of pentane was
added and the solution cooled to −30°C. After sev-
eral hours a red–violet crystalline solid started to pre-
cipitate. The supernatant solution was decanted and
the precipitate dried under high vacuum to produce
red–violet crystals (273 mg (76%), m.p. (dec.) 119°C).
EI MS: m/e (relative intensity %): 790 (1,
[Cp*Rh(SePh)]2+), 628 (2, Cp*Rh(PMe3)(SePh)2+), 552
(3, Cp*Rh(SePh)2+), 471 (18, Cp*Rh(PMe3)(SePh)+),
3.8. CpRh(PMe3)(S2C6H4) (6a)
A solution of 5 (115 mg, 0.23 mmol) in 30 ml of
THF was treated with 1,2-benzenedithiol (41 ml, 0.23
mmol) and triethylamine (65 ml, 0.47 mmol), and the
mixture was stirred for 18 h at r.t. The solvent from
the resulting dark red solution was removed under
vacuum and the residue chromatographed on Al2O3V.
Eluation with toluene gave an orange–brown band
that was taken to dryness under vacuum to give a
red–brown solid (47 mg (53%), m.p. (dec.) 207°C). EI
MS: m/e (relative intensity %): 384 (25,
CpRh(PMe3)(S2C6H4)+), 308 (100, CpRh(S2C6H4)+),
552
(3,
Cp*Rh(SePh)2+),
471
(18,
Cp*Rh-
(PMe3)(SePh)+), 395 (100, Cp*Rh(SePh)+), 314
(5, Cp*Rh(PMe3)+), 76 (47, PMe3+), 61 (64, PMe2+).
1H-NMR (CDCl3, 500 MHz): 7.57 (d, J(HH)=7.9
Hz, 4H, H(2)/H(6)), 7.01 (m, 6H, H(3)/H(4)/H(5)),
1.76 (d, J(PH)=3.2 Hz, 15H, C5Me5), 1.58 (d,
J(PH)=10.3 Hz, 9H, PMe3). 13C-NMR (CDCl3, 126
MHz): 135.6 (J(SeC)=7.8 Hz, J(C(1)C(2))=58.0 Hz,
J(C(2)C(3))=54.8 Hz, C(2)/C(6)), 133.8 (dd,
J(RhC)=0.7 Hz, J(SeC)=123.5 Hz, J(PC)=3.9 Hz,
J(C(1)C(2))=58.0 Hz, C(1)), 127.3 (J(C(3)C(4))=
55.7 Hz, C(3)/C(5)), 124.10 (J(C(3)C(4))=55.7 Hz,
C(4)), 99.4 (dd, J(RhC)=5.2 Hz, J(SeC)=2.9 Hz,
J(PC)=3.2 Hz, C5Me5), 17.2 (dd, J(RhC)=1.0 Hz,
J(SeC)=3.2 Hz, J(PC)=34.3 Hz, PMe3), 9.8 (d,
J(PC)=1.3 Hz, C5Me5).
1
168 (14, CpRh+). H-NMR (CDCl3, 250 MHz): 7.12
(m, 2H, H(3)/H(6)), 6.61 (m, 2H, H(4)/H(5)), 5.39 (d,
J(PH)=2.2 Hz, 5H, C5H5), 1.53 (d, J(PH)=11.2 Hz,
9H, PMe3). 13C-NMR (CDCl3, 62.9 MHz): 143.9
(C(1)/C(2)), 127.2 (C(3)/C(6)), 121.8 (C(4)/C(5)), 91.3
(dd, J(RhC)=4.2 Hz, J(PC)=4.2 Hz, C5H5), 17.4
(d, J(PC)=37.9 Hz, PMe3).